InMode (INMD) Assets Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.54% |
| Dec 31, 2025 | -2.45% |
| Sep 30, 2025 | -10.85% |
| Jun 30, 2025 | -17.62% |
| Mar 31, 2025 | -20.97% |
| Dec 31, 2024 | -8.99% |
| Sep 30, 2024 | 3.84% |
| Jun 30, 2024 | 17.13% |
| Mar 31, 2024 | 33.17% |
| Dec 31, 2023 | 33.97% |
| Sep 30, 2023 | 37.06% |
| Jun 30, 2023 | 40.31% |
| Mar 31, 2023 | 44.17% |
| Dec 31, 2022 | 34.66% |
| Sep 30, 2022 | 29.34% |
| Jun 30, 2022 | 36.60% |
| Mar 31, 2022 | 37.70% |
| Dec 31, 2021 | 61.80% |
| Sep 30, 2021 | 63.29% |
| Jun 30, 2021 | 60.93% |
| Mar 31, 2021 | 46.84% |
| Dec 31, 2020 | 35.43% |
| Sep 30, 2020 | 44.46% |
| Jun 30, 2020 | 132.08% |
| Dec 31, 2019 | 169.42% |